Quick answers
- What is Orabloc?
- Orabloc is a brand name of Articaine hydrochloride and epinephrine, a prescription medicine. The FDA NDC Directory lists 2 Orabloc products in 2 strengths and forms.
- Who makes Orabloc?
- Pierrel holds the FDA application for Orabloc (NDA022466, approved February 26, 2010).
- Is there a generic or store brand of Orabloc?
- Yes. The FDA NDC Directory lists 4 other products with the same active ingredients, strength and form as a Orabloc product, 4 of them generic. Ask your pharmacist whether one is right for you.
- Has Orabloc been recalled?
- No recall linked to Orabloc products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Orabloc is
Each Orabloc product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Articaine hydrochloride and epinephrine · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| articaine hydrochloride 40 mg/mL · epinephrine bitartrate 10 ug/mL injection (submucosal) | Orabloc | 2 products, 2 companies | DailyMed |
| articaine hydrochloride 40 mg/mL · epinephrine bitartrate 5 ug/mL injection (submucosal) | Orabloc | 2 products, 2 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Articaine hydrochloride and epinephrine →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA022466 | Pierrel | February 26, 2010 | 2 |
Companies that list Orabloc
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Orabloc products.
- Pierrel S.p.A.2 products
Recalls
No recall linked to Orabloc products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.